CS199647B2 - Method of preparing pharmaceutical preparations - Google Patents

Method of preparing pharmaceutical preparations Download PDF

Info

Publication number
CS199647B2
CS199647B2 CS766685A CS668576A CS199647B2 CS 199647 B2 CS199647 B2 CS 199647B2 CS 766685 A CS766685 A CS 766685A CS 668576 A CS668576 A CS 668576A CS 199647 B2 CS199647 B2 CS 199647B2
Authority
CS
Czechoslovakia
Prior art keywords
molecular weight
process according
polyalkylene glycol
optionally
preparation
Prior art date
Application number
CS766685A
Other languages
Czech (cs)
English (en)
Inventor
Lothar Ehrhardt
Ludwig Patt
Original Assignee
Otto Karl Heinz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otto Karl Heinz filed Critical Otto Karl Heinz
Publication of CS199647B2 publication Critical patent/CS199647B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
CS766685A 1975-10-17 1976-10-15 Method of preparing pharmaceutical preparations CS199647B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (1)

Publication Number Publication Date
CS199647B2 true CS199647B2 (en) 1980-07-31

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
CS766685A CS199647B2 (en) 1975-10-17 1976-10-15 Method of preparing pharmaceutical preparations

Country Status (28)

Country Link
JP (1) JPS5854122B2 (es)
AT (1) AT362510B (es)
AU (1) AU508628B2 (es)
BE (1) BE847368A (es)
CA (1) CA1079641A (es)
CH (1) CH643737A5 (es)
CS (1) CS199647B2 (es)
DE (1) DE2546577B2 (es)
DK (1) DK146194C (es)
ES (1) ES452420A1 (es)
FI (1) FI762875A (es)
FR (1) FR2327764A1 (es)
GB (1) GB1560406A (es)
GR (1) GR61268B (es)
HK (1) HK3183A (es)
HU (1) HU172533B (es)
IE (1) IE43778B1 (es)
IL (1) IL50686A (es)
MY (1) MY8400063A (es)
NL (1) NL184558C (es)
NO (1) NO144468C (es)
NZ (1) NZ182341A (es)
PH (1) PH14513A (es)
PT (1) PT65719B (es)
SE (1) SE430379B (es)
SG (1) SG63082G (es)
SU (1) SU1165223A3 (es)
ZA (1) ZA766166B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
ES2039287T3 (es) * 1987-01-14 1993-09-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
EP1039908B1 (en) * 1997-12-22 2004-02-25 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
AU2165301A (en) * 1999-12-03 2001-06-12 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US20060141038A1 (en) * 2003-06-27 2006-06-29 Bioprogress S. P. A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
NL7611295A (nl) 1977-04-19
NO144468B (no) 1981-06-01
DE2546577A1 (de) 1977-04-21
FR2327764A1 (fr) 1977-05-13
ES452420A1 (es) 1978-04-16
FR2327764B1 (es) 1979-03-02
IE43778B1 (en) 1981-05-20
AT362510B (de) 1981-05-25
NL184558B (nl) 1989-04-03
SG63082G (en) 1983-09-09
IL50686A (en) 1979-05-31
PH14513A (en) 1981-08-24
MY8400063A (en) 1984-12-31
HK3183A (en) 1983-01-20
HU172533B (hu) 1978-09-28
SE7611189L (sv) 1977-04-18
GB1560406A (en) 1980-02-06
DK146194B (da) 1983-07-25
PT65719A (fr) 1976-11-01
NZ182341A (en) 1978-09-20
BE847368A (fr) 1977-04-15
ZA766166B (en) 1978-05-30
IE43778L (en) 1977-04-17
CA1079641A (en) 1980-06-17
DK454176A (da) 1977-04-18
AU1875476A (en) 1978-04-20
FI762875A (es) 1977-04-18
SE430379B (sv) 1983-11-14
AU508628B2 (en) 1980-03-27
JPS5251014A (en) 1977-04-23
IL50686A0 (en) 1976-12-31
NO144468C (no) 1981-09-09
JPS5854122B2 (ja) 1983-12-02
DK146194C (da) 1984-01-02
ATA767976A (de) 1980-10-15
NL184558C (nl) 1989-09-01
SU1165223A3 (ru) 1985-06-30
PT65719B (fr) 1978-06-12
GR61268B (en) 1978-10-17
CH643737A5 (en) 1984-06-29
DE2546577B2 (de) 1981-04-02
NO763446L (es) 1977-04-19

Similar Documents

Publication Publication Date Title
CS199647B2 (en) Method of preparing pharmaceutical preparations
FI82186C (fi) Foerfarande foer framstaellning av en farmaceutisk tablett, vilken foerst avger en initiell sats av terapeutiskt medel och sedan frigoer det med vaesentligen konstant hastighet.
US4264573A (en) Pharmaceutical formulation for slow release via controlled surface erosion
EP0630646B1 (en) Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5266331A (en) Controlled release oxycodone compositions
EP0142561A1 (en) Long-acting nifedipine preparation
EP0404490A1 (en) Fast dissolving dosage forms
PL189329B1 (pl) Tabletka zawierająca jako składnik aktywny skuteczną terapeutycznie ilość bromowodorku galantaminy i sposób wytwarzania tej tabletki
HRP20020111A2 (en) Pharmaceutical composition containing fenofibrate and preparation method
SK14612000A3 (sk) Príprava rýchlorozpustných efavirenzových kapsúl alebo tabliet použitím superčinidiel podporujúcich rozpadavosť
KR920006908B1 (ko) 디히드로피리딘을 함유하는 고상 약제의 제조 방법
CA1191788A (en) Pharmaceutical formulations
KR0151157B1 (ko) 고흡수성 약제 조성물
EP1380297B1 (en) 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]-cyclo-hepta[1,2-b]pyridine oral compositions
JPH0338248B2 (es)
US4411882A (en) Galenical compositions
WO1980001242A1 (en) Galenical preparation
GB2061111A (en) Long acting pharmaceutical composition
IE41573B1 (en) Pharmaceutical compositions
SE465751B (sv) Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist
WO1999018957A1 (en) Stable pharmaceutical composition containing amlodipine besylate and atenolol
CZ287149B6 (en) Pharmaceutical preparation containing gemfibrozil
KR830001642B1 (ko) 맥각 알칼로이드의 경구용 조성물의 제조방법
EP0557064B1 (en) Modified release formulation
EA000740B1 (ru) Способ получения твердого терапевтически активного лекарственного средства, содержащего лекарство в малых дозах, и лекарственное средство, полученное этим способом